Newsletter
|
Hi, Elizabeth here with this month’s Co-Founders' Corner. Fluence recently applied to become a Colorado Natural Medicine (psilocybin) Training Program, and we are very excited about this groundbreaking opportunity.
Many therapists are also excited about the potential to offer life-changing healing through psychedelic-assisted treatment. However, those considering becoming Psilocybin Clinical Facilitators must carefully weigh legal, ethical, and practical challenges.
Fluence is part of the ecosystem that helps people become successful practitioners. Our graduates are already responsibly shaping this emerging treatment modality as licensed Psilocybin Facilitators in Oregon.
With that in mind, I’d like to share with you some of the things you should consider as you explore joining the ecosystem:
Licensing: To become a Psilocybin Clinical Facilitator in Colorado, clinicians must commit to specialized training, stay abreast of evolving regulations, and carefully consider their risk tolerance. Licensing boards in other jurisdictions and professions may view psilocybin therapy skeptically, demanding meticulous documentation and treatment rationales.
Legality: While Colorado has decriminalized psilocybin for adult use and therapy, it remains a Schedule I controlled substance federally–although the federal government has yet to enforce this in Oregon. This creates a complicated legal landscape that requires strict adherence to state regulations and recognition of potential federal risks, however unlikely prosecution may seem.
Financial Implications: Many banks and payment processors refuse to work with businesses that work with Schedule I substances (including cannabis), forcing them to rely on cash or cryptocurrency. Section 280E of the tax code also prevents deducting typical business expenses related to restricted substances, dramatically increasing tax burdens. Insurance coverage is scarce and expensive when available.
Ethical considerations: These are heightened when working with psilocybin, from obtaining informed consent to navigating spiritual experiences in a clinical context. Client safety protocols must be ironclad, with robust screening, emergency procedures, and secure record-keeping.
Despite these challenges, the potential benefits of psilocybin therapy for depression and other conditions are profound, and psilocybin therapy in Colorado offers a chance to be at the forefront of a paradigm shift in mental health treatment.
By proactively addressing these issues, we can contribute to the ethical development of psychedelic therapy and offer patients a revolutionary path to healing.
We anticipate hearing from Colorado within the next month or so, and if our program is approved, are excited to welcome our community into this journey. Join our waitlist to stay informed.
Thanks,
Elizabeth Nielson, Fluence Co-Founder
Join our webinar with Britt Rollins, founder of the National Psychedelic Association (NPA), and Dr. Elizabeth Nielson, Fluence Co-Founder, to explore the business essentials of running a psychedelic therapy practice.
Learn about crucial considerations like banking and insurance and how the NPA can support your professional growth.
In this webinar, you will gain an understanding of:
Psychedelic Therapy Practice Business Considerations
Liability Insurance for Facilitators
State Regulations in Oregon and Colorado
The Role of The National Psychedelics Association
Leveraging NPA’s Member Network
Date: November 26, 2024
Time: 12:00 pm Eastern
Following the discussion, we will open up for Q&A, giving you the unique opportunity to ask questions and hear more about the topics you are most interested in.
Join our upcoming Open House event, where Admissions Director Dr. Alex Camargo will explore our core Psychedelic Therapy Integration (PTI) course.
Learn what PTI offers practitioners and how it can lead to advanced courses in Ketamine-assisted Psychotherapy and Psychedelic Harm Reduction and Integration.
Date: November 20, 2024
Time: 5:00 pm Eastern
Psychedelic Therapy and Integration | January 2025 Cohort
January 3, 2025 – January 17, 2025
Trainers: Donna Sorgen, LMHC, LPC and Sabrina Santa Clara, MA, LPC, R-DMT, IFS-CTC, RYT
Advanced Psychedelic Integration
January 31, 2025 – April 18, 2025
Trainer: Alexander Camargo, PsyD
Certificate Programs Admissions Director and Trainer
Advanced Ketamine-Assisted Psychotherapy
January 28, 2025 – April 15, 2025
Trainer: Jayne Gumpel, LCSW
Psychedelic Psychopharmacology
An in-depth look at the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
January 6 - March 31, 2025
Trainer: Kelan Thomas, PharmD, MS, BCPP
Our new mobile app will help you continue your learning journey anytime, anywhere. Stay on top of your professional development right from your phone, with access to all your courses.
Stay tuned for your invite email this Monday.
Ecstatic Integration: Is the psychedelic renaissance over? 16 experts give us their take
Press Release: Fluence and Heal Ukraine Trauma Collaborate on Ketamine-Assisted Psychotherapy Training in Ukraine for Veterans' Mental Health
Tricycle Day: Fluence and Heal Ukraine Trauma just completed the world’s first veteran-focused KAP training program
